UroGen Pharma Ltd. (URGN)
NASDAQ·Healthcare·Biotechnology
$40.77
-0.28%
Mkt Cap $2.05B
Analyst Ratings
Buy
8
Hold
0
Sell
0
Price Target (15 analysts)
$44.20
Range $40.00 – $50.00
Implied Upside
+8.4%
Consensus $44.20 vs current $40.77
NASDAQ·Healthcare·Biotechnology
$40.77
-0.28%
Mkt Cap $2.05B
Buy
8
Hold
0
Sell
0
Price Target (15 analysts)
$44.20
Range $40.00 – $50.00
+8.4%
Consensus $44.20 vs current $40.77